California OTC Firm Written Up for Missing Validations, Product Reviews By Sam | September 25, 2019 The FDA cited an OTC drugmaker in California for violations at its facility involving its manufacturing equipment and quality system. Source: Drug Industry Daily Posted in Drug Industry Daily